Identification of Methylation Immune Subtypes and Establishment of a Prognostic Signature for Gliomas Using Immune-Related Genes
Zhengang Hu(Central South University), Quan Cheng(Central South University), Yunying Huang(Guangzhou Medical University), Zeyu Wang(Anhui University), Xun Zhang(Zaozhuang University), Hao Zhang(Northwestern Polytechnical University), Zhixiong Liu(Central South University), Hui Cao(Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine), Jiahao Xu(Xuzhou Medical College), Ziyu Dai(Central South University)
Cited by 4
Related Papers
Glioma targeted therapy: insight into future of molecular approaches
|Molecular Cancer|2022|727
CGCG clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2016|650
PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application
|Drug Delivery|2021|578
PARP inhibitor resistance: the underlying mechanisms and clinical implications
|Molecular Cancer|2020|548
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
|Journal of Experimental & Clinical Cancer Research|2021|535